These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7531920

  • 1. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ, Knight L, Charan N.
    West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
    [No Abstract] [Full Text] [Related]

  • 2. Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
    Nakhoul F, Green J, Abassi ZA, Carter A.
    Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396
    [No Abstract] [Full Text] [Related]

  • 3. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
    List AF, Kummet TD, Adams JD, Chun HG.
    Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
    [No Abstract] [Full Text] [Related]

  • 4. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O, Yürekli BS, Pürnak T, Aksu S, Haznedaroglu IC.
    Ann Pharmacother; 2004 Sep; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract] [Full Text] [Related]

  • 5. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C, Coiffier B.
    Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
    [No Abstract] [Full Text] [Related]

  • 6. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    Frame JN, Dahut WL, Crowley S.
    N Engl J Med; 1992 Nov 05; 327(19):1396-7. PubMed ID: 1406856
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
    Mulligan SP, Dean MG.
    Aust N Z J Med; 1994 Aug 05; 24(4):406-7. PubMed ID: 7980241
    [No Abstract] [Full Text] [Related]

  • 8. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
    Moutouh-de Parseval LA, Weiss L, DeLap RJ, Knight RD, Zeldis JB.
    J Clin Oncol; 2007 Nov 01; 25(31):5047. PubMed ID: 17971612
    [No Abstract] [Full Text] [Related]

  • 9. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar 01; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 10. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Montalban C, Liaño F, Aguilera A.
    Postgrad Med J; 1994 Sep 01; 70(827):651-2. PubMed ID: 7971632
    [Abstract] [Full Text] [Related]

  • 11. Fludarabine phosphate--looking forward.
    Cheson BD.
    Semin Oncol; 1990 Oct 01; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM.
    J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774
    [Abstract] [Full Text] [Related]

  • 13. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Apr 01; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 14. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct 01; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract] [Full Text] [Related]

  • 15. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
    Schilling PJ, Vadhan-Raj S.
    N Engl J Med; 1990 Sep 20; 323(12):833-4. PubMed ID: 1697401
    [No Abstract] [Full Text] [Related]

  • 16. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr 20; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 17. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
    Calvo-Villas JM, Urcuyo BM, Umpierrez AM, Sicilia F.
    Onkologie; 2008 Apr 20; 31(4):197-9. PubMed ID: 18418022
    [Abstract] [Full Text] [Related]

  • 18. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K, Mazza JJ, Clouse LH.
    Am J Hematol; 2003 Mar 20; 72(3):212-5. PubMed ID: 12605395
    [Abstract] [Full Text] [Related]

  • 19. Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Kosseifi SG, Vyas B, Vyas H, Krishnaswamy G, Smith S.
    Tenn Med; 2009 Oct 20; 102(10):33-6. PubMed ID: 19899317
    [No Abstract] [Full Text] [Related]

  • 20. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM, Spilove L, Rhodes R, Garfinkel H, Pezzimenti J.
    Conn Med; 1993 Oct 20; 57(10):651-4. PubMed ID: 8275684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.